rrd78240_88026.html

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UpSAlTLnCUXKvN3sAm/gR80Y1abThaG0k6BraKEQ3+hlK1Wwdp7Uu3J6qJ6PWbgz j6oL45Nnd7uWI2zRPfJ+WQ== 0001181431-05-049371.txt : 20050829 0001181431-05-049371.hdr.sgml : 20050829 20050829180623 ACCESSION NUMBER: 0001181431-05-049371 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050825 FILED AS OF DATE: 20050829 DATE AS OF CHANGE: 20050829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREAT POINT PARTNERS LLC CENTRAL INDEX KEY: 0001281446 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24241 FILM NUMBER: 051056626 MAIL ADDRESS: STREET 1: 2 PICKWICK PLAZA STREET 2: STE 450 CITY: GREENWICH STATE: CT ZIP: 06830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PANACOS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001040017 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 113238476 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-1551 MAIL ADDRESS: STREET 1: 134 COOLIDGE AVE CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: V I TECHNOLOGIES INC DATE OF NAME CHANGE: 19980209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JAY JEFFREY R CENTRAL INDEX KEY: 0001239607 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24241 FILM NUMBER: 051056627 BUSINESS ADDRESS: STREET 1: WHITNEY & CO. STREET 2: 177 BROAD STREET CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-971-3300 MAIL ADDRESS: STREET 1: GREAT POINT PARTNERS, LLC STREET 2: 2 PICKWICK PLAZA, SUITE 450 CITY: GREENWICH STATE: CT ZIP: 06830 4 1 rrd90732.xml 4 X0202 4 2005-08-25 1 0001040017 PANACOS PHARMACEUTICALS, INC. PANC 0001281446 GREAT POINT PARTNERS LLC 2 PICKWICK PLAZA, SUITE 450, GREENWICH CT 06830 0 0 1 0 0001239607 JAY JEFFREY R 2 PICKWICK PLAZA, SUITE 450 GREENWICH CT 06830 0 0 1 0 Common Stock 2005-08-25 4 S 0 66693 10.2767 D 450191 I By Biomedical Value Fund, L.P. Common Stock 2005-08-25 4 S 0 66692 10.2767 D 1012308 I By Biomedical Offshore Value Fund, Ltd. Common Stock 62500 I By Jeffrey R. Jay, M.D. Represents average per share sales price. See Annex A attached hereto for complete sale details. Securities held directly by Biomedical Value Fund, L.P. ("BMVF") and indirectly by Great Point Partners, LLC ("Great Point") and Jeffrey R. Jay, M.D. ("Dr. Jay"). Great Point is the investment manager of BMVF and by virtue of such status may be deemed to be the beneficial owner of securities held by BMVF. Dr. Jay, as senior managing member of Great Point, has voting and investment power with respect to securities held by BMVF and may be deemed to be the beneficial owner of securities held by BMVF. Great Point and Dr. Jay each disclaim beneficial ownership of shares held by BMVF, except to the extent of its or his pecuniary interest and this report shall not be deemed to be an admission that either is the beneficial owner of such securities. Securities held directly by Biomedical Offshore Value Fund, Ltd. ("BOVF") and indirectly by Great Point and Dr. Jay. Great Point is the investment manager of BOVF and by virtue of such status may be deemed to be the beneficial owner of securities held by BOVF. Dr. Jay, as senior managing member of Great Point, has voting and investment power with respect to securities held by BOVF. Great Point and Dr. Jay each disclaim beneficial ownership of shares held by BOVF, except to the extent of its or his pecuniary interest and this report shall not be deemed to be an admission that either is the beneficial owner of such securities. Securities held directly by Dr. Jay. None of BMVF, BOVF or Great Point has any pecuniary interest in such securities. Great Point Partners, LLC By: Jeffrey R. Jay, M.D. 2005-08-29 Jeffrey R. Jay, M.D. 2005-08-29 EX-99.1 2 rrd78240_88026.htm ANNEX A SALE DETAILS rrd78240_88026.html

ANNEX A
Details of sale of 66,693 shares of
Panacos Pharmaceuticals, Inc. by BMVF on August 25, 2005
	Shares			Price Per Share
	366			$10.18
	254			$10.19
	5,144			$10.20
	3,857			$10.21
	5,083			$10.22
	3,432			$10.23
	4,550			$10.24
	5,557			$10.25
	2,987			$10.26
	2,517			$10.27
	695			$10.28
	2,605			$10.29
	9,790			$10.30
	1,624			$10.31
	1,655			$10.32
	5,050			$10.33
	1,820			$10.34
	4,495			$10.35
	4,000			$10.36
	950			$10.37
	262			$10.38

Details of sale of 66,692 shares of
Panacos Pharmaceuticals, Inc. by BOVF on August 25, 2005
	Shares			Price Per Share
	366			$10.18
	254			$10.19
	5,144			$10.20
	3,858			$10.21
	5,083			$10.22
	3,432			$10.23
	4,550			$10.24
	5,557			$10.25
	2,987			$10.26
	2,518			$10.27
	694			$10.28
	2,605			$10.29
	9,790			$10.30
	1,621			$10.31
	1,655			$10.32
	5,050			$10.33
	1,820			$10.34
	4,495			$10.35
	4,000			$10.36
	950			$10.37
	263			$10.38




2

-----END PRIVACY-ENHANCED MESSAGE-----